Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
Date:1/18/2011

oducts of high therapeutic value for human and veterinary medicine. In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment Prescription Medicines on research and development. For more information please visit www.boehringer-ingelheim.com.

Forward-Looking StatementsThis news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2009, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.  

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign) and difficulties or delays in manufacturing our products.  In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement.  Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
2. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
3. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
4. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
6. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
7. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
10. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
11. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Calif. , May 6, 2015 ... biotechnology company in the emerging field of regenerative ... a meeting with the investment community to review ... cells) in spinal cord injury on Friday, May ... 1/2a clinical trial and future planned clinical activities ...
(Date:5/6/2015)... BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today reported ... Total revenues for the first quarter ... $136.8 million in the first quarter of 2014. Revenues ... million in royalty and license payments from PDL,s licensees ... net royalty payments from acquired royalty rights and a ...
(Date:5/6/2015)... PHILADELPHIA, May 6, 2015 Lannett Company, Inc. ... its fiscal 2015 third quarter ended March 31, 2015.  ... net sales rose 24% to $99.4 million from $80.0 ... 35% to $75.6 million, or 76% of net sales, ... and development (R&D) expenses decreased to $9.2 million from ...
Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8
... Marken, a leading logistics specialist supporting the life science industry, today announced ... office will handle the growing demand for management and support of Marken,s Japanese ... "Opening our ... science companies in Japan and across the Asia Pacific ...
... NEWTON, Mass. , Aug. 5 Microfluidics International Corporation (OTC Bulletin Board: ... Tuesday, August 10, 2010 , at 8:30am ET . , ... (Logo: http://photos.prnewswire.com/prnh/20090811/NE59652LOGO ) , , , ... ) , , , ...
Cached Medicine Technology:Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 2Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 3Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 4
(Date:5/6/2015)... Edvance360 LMS-SN , a leader in ... Software & Information Industry Association's (SIIA) 30th annual ... Learning Management Solution" category. Edvance360 LMS-SN won the ... this award seven years running, continued proof that Edvance360 ... industry. , "The honor of being a CODiE ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child ... center in Florida while under the influence of Flakka, according ... tapes released by CBS4’s Peter D’Oench records Doby distraught in ... is around one year old. The drug treatment center in ... not named. The residents polled by CBS Miami express concern ...
(Date:5/6/2015)... BC (PRWEB) May 06, 2015 ... hydrotherapy supplier, is excited to announce a new ... help reduce the industry’s carbon footprint while improving ... kits feature Eco-Flex™, the world’s first ... is a game-changer for hydrotherapists,” claims the company’s ...
(Date:5/6/2015)... 06, 2015 “ SideChef ” was featured on ... at the latest and coolest applications on the market for iOS, ... expert, conducted the app review and shared with viewers how this ... day when to be a good navigator people had to know ... now everyone is a master navigator. Well what if people could ...
(Date:5/6/2015)... 06, 2015 vcfo, a specialized consulting ... and operational support to optimize business performance and productivity, ... Lynch and Michael Scheaffer. Both Lynch and Scheaffer have ... experience. , “We are delighted to add Jack ... CEO. “Leveraging their background in financial management and leadership, ...
Breaking Medicine News(10 mins):Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2
... - BELLUS Health Inc. (TSX: BLU) reported today its ... and commented on the status of its efforts to ... reports a net loss of $11,520,000 ($0.23 per share), ... period in the previous year. For the year ended ...
... Toys That Speak To Autism" and Provides Important ... This weekend, Toys"R"Us and Babies"R"Us stores nationwide ... to benefit Autism Speaks, the nation,s leading organization ... funding research into the causes, prevention and treatments ...
... SANTA ANA, Calif., Feb. 26 MIND Research Institute ... of Advanced,Medical Optics (AMO), was recently elected to MIND,s ... education. He serves on numerous boards and,committees at the ... chairs the UCI,Foundation,s Board of Trustees, the Engineering Advisory ...
... Inn & Spa,s Artist,s Cottage is the next generation ... http://www.newscom.com/cgi-bin/prnh/20090226/NYFNSH01 )"Traditional spas just focus on the wellness ... Valley Inn & Spa. "At Ojai Valley Inn & ... our guests the opportunity to treat not just their ...
... and Make Patient Safety a PriorityPORTLAND, Ore., Feb. ... healthcare payers caught between member demands for better ... they also wrestle with business restructuring, declining budgets ... complexity of new technologies, treatments and drugs continues ...
... and News/Talk 750 WSB are teaming up to extend the Prostate Proactivity ... Saturday, February 28, from 9 a.m. to 5 p.m. at Kroger located ... ... February 26, 2009 -- Metro Atlanta men will have an additional opportunity ...
Cached Medicine News:Health News:BELLUS Health reports results for the fourth quarter of 2008 2Health News:BELLUS Health reports results for the fourth quarter of 2008 3Health News:BELLUS Health reports results for the fourth quarter of 2008 4Health News:BELLUS Health reports results for the fourth quarter of 2008 5Health News:BELLUS Health reports results for the fourth quarter of 2008 6Health News:BELLUS Health reports results for the fourth quarter of 2008 7Health News:BELLUS Health reports results for the fourth quarter of 2008 8Health News:BELLUS Health reports results for the fourth quarter of 2008 9Health News:BELLUS Health reports results for the fourth quarter of 2008 10Health News:BELLUS Health reports results for the fourth quarter of 2008 11Health News:BELLUS Health reports results for the fourth quarter of 2008 12Health News:BELLUS Health reports results for the fourth quarter of 2008 13Health News:BELLUS Health reports results for the fourth quarter of 2008 14Health News:BELLUS Health reports results for the fourth quarter of 2008 15Health News:BELLUS Health reports results for the fourth quarter of 2008 16Health News:BELLUS Health reports results for the fourth quarter of 2008 17Health News:BELLUS Health reports results for the fourth quarter of 2008 18Health News:BELLUS Health reports results for the fourth quarter of 2008 19Health News:BELLUS Health reports results for the fourth quarter of 2008 20Health News:BELLUS Health reports results for the fourth quarter of 2008 21Health News:BELLUS Health reports results for the fourth quarter of 2008 22Health News:BELLUS Health reports results for the fourth quarter of 2008 23Health News:BELLUS Health reports results for the fourth quarter of 2008 24Health News:BELLUS Health reports results for the fourth quarter of 2008 25Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 2Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 3Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Introducing a Kitchen for Your Mind: The Ojai Valley Inn & Spa Artist's Cottage 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 3Health News:Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign 2Health News:Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign 3
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: